Department of Mathematics, Faculty of Science, Mahidol University, Bangkok, 10400, Thailand.
Department of Molecular Tropical Medicine and Genetics, Faculty of Tropical Medicine, Mahidol University, Bangkok, 10400, Thailand.
BMC Med. 2023 Sep 4;21(1):340. doi: 10.1186/s12916-023-03047-7.
Ketone bodies (KBs) are an alternative energy supply for brain functions when glucose is limited. The most abundant ketone metabolite, 3-β-hydroxybutyrate (BOHBUT), has been suggested to prevent or delay cognitive impairment, but the evidence remains unclear. We triangulated observational and Mendelian randomization (MR) studies to investigate the association and causation between KBs and cognitive function.
In observational analyses of 5506 participants aged ≥ 45 years from the Whitehall II study, we used multiple linear regression to investigate the associations between categorized KBs and cognitive function scores. Two-sample MR was carried out using summary statistics from an in-house KBs meta-analysis between the University College London-London School of Hygiene and Tropical Medicine-Edinburgh-Bristol (UCLEB) Consortium and Kettunen et al. (N = 45,031), and publicly available summary statistics of cognitive performance and Alzheimer's disease (AD) from the Social Science Genetic Association Consortium (N = 257,841), and the International Genomics of Alzheimer's Project (N = 54,162), respectively. Both strong (P < 5 × 10) and suggestive (P < 1 × 10) sets of instrumental variables for BOHBUT were applied. Finally, we performed cis-MR on OXCT1, a well-known gene for KB catabolism.
BOHBUT was positively associated with general cognitive function (β = 0.26, P = 9.74 × 10). In MR analyses, we observed a protective effect of BOHBUT on cognitive performance (inverse variance weighted: β = 7.89 × 10, P = 1.03 × 10; weighted median: β = 8.65 × 10, P = 9.60 × 10) and a protective effect on AD (β = - 0.31, odds ratio: OR = 0.74, P = 3.06 × 10). Cis-MR showed little evidence of therapeutic modulation of OXCT1 on cognitive impairment.
Triangulation of evidence suggests that BOHBUT has a beneficial effect on cognitive performance. Our findings raise the hypothesis that increased BOHBUT may improve general cognitive functions, delaying cognitive impairment and reducing the risk of AD.
酮体 (KBs) 是葡萄糖有限时大脑功能的替代能量供应。最丰富的酮代谢物 3-β-羟基丁酸 (BOHBUT) 被认为可以预防或延迟认知障碍,但证据仍不清楚。我们将观察性研究和孟德尔随机化 (MR) 研究相结合,以调查 KBs 与认知功能之间的关联和因果关系。
在年龄≥45 岁的 Whitehall II 研究的 5506 名参与者的观察性分析中,我们使用多元线性回归来研究分类 KBs 与认知功能评分之间的关系。使用 UCL-伦敦卫生与热带医学学院-爱丁堡-布里斯托尔 (UCLEB) 联盟和 Kettunen 等人之间的内部 KBs 荟萃分析的汇总统计数据进行两样本 MR(N=45031),以及来自社会科学遗传协会联盟 (N=257841) 的认知表现和阿尔茨海默病 (AD) 的公开汇总统计数据,以及国际阿尔茨海默病基因组学项目 (N=54162)。分别应用 BOHBUT 的强 (P<5×10) 和提示 (P<1×10) 工具变量集。最后,我们对 OXCT1 进行顺式-MR,OXCT1 是一种众所周知的 KB 分解代谢基因。
BOHBUT 与一般认知功能呈正相关 (β=0.26,P=9.74×10)。在 MR 分析中,我们观察到 BOHBUT 对认知表现有保护作用 (逆方差加权:β=7.89×10,P=1.03×10;加权中位数:β=8.65×10,P=9.60×10),对 AD 有保护作用 (β=−0.31,优势比:OR=0.74,P=3.06×10)。顺式-MR 几乎没有证据表明 OXCT1 对认知障碍有治疗调节作用。
证据的三角剖分表明 BOHBUT 对认知表现有有益的影响。我们的研究结果提出了一个假设,即增加 BOHBUT 可能改善一般认知功能,延迟认知障碍并降低 AD 的风险。